Corporate Profile for Endovasc Ltd. Inc., dated Feb. 1, 2002.Business Editors --(BUSINESS WIRE) The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and online services, including all of the leading Internet-based services.
Published Date: Feb. 1, 2002
Company Name: Endovasc Ltd. Inc.
Address: 15001 Walden Road, Suite 108
Montgomery, TX 77356
Main Telephone
Number: 936/448-2222; Toll Free: 866/999-ENDV
Internet Home
Page Address
(URL) www.endovasc.com
Chief Executive
Officer: David P. Summers, Ph.D.
Chief Financial
Officer: M. Dwight Cantrell
Investor Relations
Contact: John T. (Jack) Sorbi, Jr.
Business number: 936/448-2222
E-mail address: jack@endovasc.com
Public Relations
Contact: John T. (Jack) Sorbi, Jr.
Business number: 936/448-2222
E-mail address: jack@endovasc.com
Industry: BioTechnology/BioPharmaceutical
Trading Symbol/
Exchange: (OTCBB:ENDV)(Berlin:ED7)
Market Makers: Brokerage/America Inc.; Knight Securities LP;
Paragon Capital Corp.; Schwab Capital Markets LP;
Fleet Trading/Fleet Securities Inc.
Company description: Endovasc Ltd. Inc. is a biopharmaceutical/biotech company pioneering liposomal drug delivery technology designed to target patients with cardiovascular and peripheral limb ischemia. The Company's core technology consists of the ability to formulate and produce extremely small drug microspheres called liposomes Liposomes Aqueous compartments enclosed by lipid bilayer membranes; liposomes are also known as lipid vesicles. Phospholipid molecules consist of an elongated nonpolar (hydrophobic) structure with a polar (hydrophilic) structure at one end. , with timed-release of therapeutic agents within specific blood vessels Blood vessels Tubular channels for blood transport, of which there are three principal types: arteries, capillaries, and veins. Only the larger arteries and veins in the body bear distinct names. or targeted wound sites. Endovasc's signature drug, Liprostin(TM), liposomal encapsulated PGE-1, is a patented drug and drug-delivery system that targets patients with cardiovascular and occlusive occlusive /oc·clu·sive/ (o-kloo´siv) pertaining to or causing occlusion. oc·clu·sive adj. 1. Occluding or tending to occlude. 2. vascular disease and other indications. The drug can be delivered as adjunct therapy to an angioplasty procedure. PGE-1 has also shown that it may reduce or prevent reblockage (restenosis) of target vessels. The Company's other product is NRA NRA (National Rifle Association of America) organization that encourages sharpshooting and use of firearms for hunting. [Am. Pop. Culture: NCE, 1895] See : Hunting , Nicotine Receptor Agonist agonist /ag·o·nist/ (ag´ah-nist) 1. one involved in a struggle or competition. 2. agonistic muscle. 3. , an angiogenesis angiogenesis /an·gio·gen·e·sis/ (-jen´e-sis) vasculogenesis; development of blood vessels either in the embryo or in the form of neovascularization or revascularization. an·gi·o·gen·e·sis n. agent. NRA is an isolated molecule from the tobacco plant that has been found to promote the growth of new, healthy blood vessels and tissue at a wound or occluded site. Stanford University Stanford University, at Stanford, Calif.; coeducational; chartered 1885, opened 1891 as Leland Stanford Junior Univ. (still the legal name). The original campus was designed by Frederick Law Olmsted. David Starr Jordan was its first president. researchers, under direction of Dr. John Cooke John Cooke may refer to:
Endovasc Ltd. Inc. is continuing to consolidate its position and is confident that its patented drug delivery systems will have a significant impact on the future management of cardiology cardiology Medical specialty dealing with heart diseases and disorders. It began with the 1749 publication by Jean Baptiste de Sénac of contemporary knowledge of the heart. Diagnostic methods improved in the 19th century, and in 1905 the electrocardiograph was invented. , radiology and oncology patients. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion